Log in to your Inderes Free account to see all free content on this page.
Raysearch Laboratories
190.80 SEK
+2.58 %
Less than 1K followers
RAY B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+2.58 %
-10.84 %
-16.32 %
-13.47 %
-28.81 %
-30.62 %
+150.39 %
+119.82 %
+242.08 %
RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
6.54B SEK
Turnover
27.59M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
29.4.
2026
Interim report Q1'26
7.5.
2026
General meeting '26
8.5.
2026
Annual dividend
All
Webcasts
Press releases
ShowingAll content types
Year-end report 2025: Record revenue and strong earnings growth despite currency headwinds
The Royal Marsden NHS Foundation Trust uses RayStation for online adaptive treatments with conventional C-arm linacs
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
